Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 31  •  09:42AM ET
1.25
Dollar change
+0.02
Percentage change
1.63
%
Index- P/E- EPS (ttm)-2.25 Insider Own1.56% Shs Outstand8.71M Perf Week0.00%
Market Cap10.89M Forward P/E- EPS next Y-1.10 Insider Trans0.00% Shs Float8.58M Perf Month11.61%
Enterprise Value17.79M PEG- EPS next Q-0.41 Inst Own2.23% Short Float1.14% Perf Quarter4.95%
Income-14.25M P/S1.62 EPS this Y25.61% Inst Trans-4.79% Short Ratio1.10 Perf Half Y5.93%
Sales6.74M P/B- EPS next Y48.84% ROA-34.98% Short Interest0.10M Perf YTD-33.16%
Book/sh-0.41 P/C0.93 EPS next 5Y33.50% ROE-655.00% 52W High2.87 -56.44% Perf Year-48.13%
Cash/sh1.34 P/FCF- EPS past 3/5Y25.06% 16.27% ROIC- 52W Low0.95 31.58% Perf 3Y-84.61%
Dividend Est.- EV/EBITDA- Sales past 3/5Y109.17% 62.42% Gross Margin15.74% Volatility4.65% 7.23% Perf 5Y-95.73%
Dividend TTM- EV/Sales2.64 EPS Y/Y TTM43.01% Oper. Margin-288.20% ATR (14)0.08 Perf 10Y-98.75%
Dividend Ex-Date- Quick Ratio1.69 Sales Y/Y TTM-28.72% Profit Margin-211.61% RSI (14)48.91 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio1.82 EPS Q/Q41.99% SMA20-3.17% Beta1.50 Target Price2.50
Payout- Debt/Eq- Sales Q/Q-3.28% SMA500.34% Rel Volume0.27 Prev Close1.23
Employees117 LT Debt/Eq- EarningsAug 19 BMO SMA200-4.29% Avg Volume89.36K Price1.25
IPOMar 05, 2008 Option/ShortNo / Yes EPS/Sales Surpr.20.63% -4.95% Trades Volume1,889 Change1.63%
Date Action Analyst Rating Change Price Target Change
Oct-08-21Initiated ROTH Capital Buy $7
Jul-29-21Initiated Aegis Capital Buy $10
Dec-01-20Initiated Cantor Fitzgerald Overweight $9
Dec-16-13Initiated Oppenheimer Outperform $26
Aug-28-25 07:00AM
Aug-20-25 03:05AM
Aug-19-25 07:10AM
07:00AM
Aug-12-25 07:00AM
07:00AM Loading…
Jul-29-25 07:00AM
Jul-08-25 07:00AM
Jun-10-25 07:00AM
May-22-25 01:21AM
May-21-25 07:00AM
May-14-25 08:37PM
May-08-25 07:00AM
Apr-22-25 09:24AM
Apr-21-25 07:00AM
Mar-06-25 07:15AM
07:00AM Loading…
07:00AM
Feb-20-25 07:00AM
Feb-13-25 08:00AM
Nov-21-24 07:30AM
Nov-19-24 07:00AM
Nov-12-24 07:00AM
Nov-07-24 07:00AM
Oct-31-24 08:00AM
Oct-29-24 08:00AM
Oct-08-24 07:00AM
Sep-30-24 07:00AM
Aug-23-24 08:55AM
Aug-22-24 07:00AM
Aug-12-24 07:11AM
07:00AM
07:00AM Loading…
Jul-31-24 07:00AM
Jul-23-24 08:48AM
Jul-17-24 08:00AM
Jul-02-24 07:00AM
Jun-25-24 07:00AM
May-30-24 08:02AM
May-23-24 11:52AM
11:00AM
07:00AM
May-21-24 07:03AM
May-09-24 07:00AM
Apr-16-24 07:00AM
Apr-11-24 07:00AM
Apr-02-24 07:00AM
Mar-28-24 09:00AM
Mar-20-24 09:00AM
Mar-19-24 09:00AM
Mar-13-24 09:00AM
Mar-07-24 12:53PM
09:20AM
07:00AM
Mar-06-24 07:00AM
Mar-05-24 07:00AM
Feb-28-24 07:00AM
Feb-26-24 07:00AM
Feb-22-24 07:00AM
Feb-21-24 07:00AM
Feb-20-24 07:00AM
Feb-06-24 07:08AM
Jan-23-24 07:00AM
Jan-17-24 07:00AM
Jan-12-24 12:00PM
Dec-21-23 07:00AM
Dec-19-23 07:00AM
Dec-05-23 07:00AM
Nov-28-23 07:00AM
Nov-16-23 09:57AM
Nov-15-23 07:00AM
Nov-08-23 07:00AM
Nov-02-23 07:00AM
Oct-31-23 07:00AM
Oct-18-23 07:00AM
Sep-27-23 07:00AM
Aug-17-23 07:00AM
Aug-15-23 07:00AM
Aug-01-23 07:00AM
Jul-25-23 07:00AM
Jul-19-23 07:00AM
Jul-17-23 08:15AM
07:30AM
Jul-12-23 07:00AM
Jul-03-23 07:00AM
Jun-22-23 05:50PM
Jun-21-23 07:00AM
May-24-23 07:00AM
May-18-23 07:00AM
May-09-23 07:00AM
May-04-23 07:00AM
May-02-23 07:00AM
Apr-28-23 09:00AM
Apr-27-23 07:00AM
Mar-30-23 04:01PM
Mar-29-23 07:00AM
Mar-21-23 01:45PM
Mar-15-23 08:00AM
Mar-13-23 01:56AM
Mar-09-23 07:00AM
Mar-06-23 07:00AM
06:55AM
Mar-01-23 04:01PM
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, Industrial Applications, and Human Health. The Agriculture segment develops seed traits, agrochemical products, and agro biological products to improve plant performance. The Industrial Applications focuses on the development and commercialization of improved castor bean seeds for industrial uses. The Human Health segment involves discovery and development of human microbiome-based therapeutics. The company was founded by Amir Barzilay and Hagai Karchi on October 10, 1999 and is headquartered in Rehovot, Israel.